课题基金 / 基金详情

Effects of acute administration of the Phenothiazinium Chromophore Methylene blue during life threatening cyanide intoxication

Effects of acute administration of the Phenothiazinium Chromophore Methylene blue during life threatening cyanide intoxication
在危及生命的氰化物中毒期间急性施用吩噻嗪发色团亚甲蓝的影响
批准号:
9357397
负责人:
Philippe A Haouzi
金额:
$19.45万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-30 至 2019-08-31

项目摘要

项目成果

Philippe A Haouzi的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结/文摘
英文摘要
PROJECT SUMMARY/ABSTRACT Cyanide, a very toxic mitochondrial poison, has a wide spread usage in various industrial activities. It is present in many synthetic materials and can be released in gaseous form during a house fire. Since CN can be easily weaponized, it is considered as a serious threat for the civilian population. The treatment of acute CN intoxication relies on (1) specific antidotes, to decrease the concentration of CN in the blood and tissues, and (2) symptomatic treatments, essential at the early stage of exposure, consisting in an aggressive ventilatory and circulatory support, akin to the treatment of any conditions associated with cardio-respiratory depression. We have recently found that the phenothiazinium chromophore methylene blue (MB), which can counteract the toxicity of various mitochondrial poisons (hydrogen sulfide and Azure B), can also oppose CN- induced acute circulatory failure. The mechanisms of action of MB as well as the limits of its efficacy, following CN intoxication, remain to be determined. The objective of our proposal is first to validate our preliminary observations and to determine the interest of the use of MB during and following CN intoxication induced coma and cardiac failure in the rat. We will determine if MB can improve the immediate and long-term outcome of CN intoxication when used alone and more importantly as an adjuvant of antidotes already approved for the treatment of CN intoxication. Second, we will explore the potential mechanisms of action of MB, using isolated contracting cardiomyocytes intoxicated with CN. These studies will be performed in collaboration with the group of Dr. Joseph Cheung, Temple University. Since MB has been used for decades for treating methemoglobinemia (1-2 mg/kg iv) in humans, our goal is to reposition methylene blue, a drug already on the WHO's list of essential medications, as a treatment of CN intoxication.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1097/shk.0000000000000732
发表时间: 2017-03
期刊: Shock (Augusta, Ga.)
影响因子: --
作者: [Haouzi P, Tubbs N, Rannals MD, Judenherc-Haouzi A, Cabell LA, McDonough JA, Sonobe T]
通讯作者: Sonobe T
Restoring The Mechanical Properties of the Respiratory System as a Treatment of Fentanyl Overdose-Induced Hypoventilation using Kappa Agonists
  • 批准号:
    10766378
  • 项目类别:
  • 资助金额:
    $24.15万
  • 财政年份:
    2022
  • 负责人:
    Philippe A Haouzi
  • 依托单位:
Restoring The Mechanical Properties of the Respiratory System as a Treatment of Fentanyl Overdose-Induced Hypoventilation using Kappa Agonists
Treatment of Fentanyl Overdose-Induced Respiratory Failure by Low-Dose Dexmedetomidine
  • 批准号:
    10828679
  • 项目类别:
  • 资助金额:
    $50.09万
  • 财政年份:
    2020
  • 负责人:
    Philippe A Haouzi
  • 依托单位:
Treatment of Fentanyl Overdose-Induced Respiratory Failure by Low-Dose Dexmedetomidine
海外基金